95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
88831098.78%
Revenue growth above 1.5x NEM's 17.12%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
88831098.78%
Gross profit growth above 1.5x NEM's 38.42%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
392.41%
EBIT growth above 1.5x NEM's 190.94%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
392.41%
Operating income growth above 1.5x NEM's 190.94%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-377.97%
Negative net income growth while NEM stands at 159.36%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-350.00%
Negative EPS growth while NEM is at 162.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-350.00%
Negative diluted EPS growth while NEM is at 162.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
285.84%
OCF growth above 1.5x NEM's 2.26%. David Dodd would confirm a clear edge in underlying cash generation.
285.84%
FCF growth above 1.5x NEM's 104.13%. David Dodd would verify if the firm’s strategic investments yield superior returns.
355.10%
10Y revenue/share CAGR above 1.5x NEM's 27.23%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
355.10%
5Y revenue/share CAGR above 1.5x NEM's 15.81%. David Dodd would look for consistent product or market expansions fueling outperformance.
355.10%
3Y revenue/share CAGR above 1.5x NEM's 6.81%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.75%
Negative equity/share CAGR over 10 years while NEM stands at 327.48%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-3.75%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-3.75%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.72%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.